Clinical Trial Update: A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, randomized, placebo-controlled trial evaluating quetiapine for depression in adolescents with Bipolar I Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: University of Cincinnati | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED